Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics - PowerPoint PPT Presentation

Loading...

PPT – Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics PowerPoint presentation | free to download - id: 81d918-MzY2N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics

Description:

The Global Intravenous (IV) Iron Drugs Market report analyzes the global iron products industry. For more mail: vikas@konceptanalytics.com – PowerPoint PPT presentation

Number of Views:5

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics


1
Global I.V. Iron Drugs Market Report
----------------------------------------- 2016
View Report Details
2
View Report Details
  • Executive Summary
  • Iron is vital for multiple bodily functions, most
    importantly for the production of hemoglobin for
    red blood cells which are responsible for
    transporting oxygen in the blood. As an element,
    the only source of iron is from the diet. There
    is no way the body can produce iron itself.
    Intravenous (IV) treatment, in a broad sense,
    covers all the types of medications delivered
    intravenously, i.e. directly into the vein,
    through intravenous drip. Compared to the other
    routes of infusing medications, the intravenous
    route is the fastest way to deliver fluids and
    medications throughout the body. The first iron
    product for intravenous use was
    high-molecular-weight iron dextran. Some of the
    major areas of IV iron application include
    gynecology, gastroenterology, oncology and
    surgeries. Hemoglobin, Ferritin, Transferrin, and
    Hepcidin are major molecules which are critical
    in the function and regulation of iron.
  • The key factors driving growth of the global I.V.
    iron industry include increase in number of
    dialysis cases, increasing global healthcare
    expenditures, rising ageing population,
    increasing life expectancy rate, growing number
    of ERSD patients and rising medicines
    expenditures. Some of the noteworthy trends and
    developments of this industry are new product
    development, introduction of the first generation
    drugs InFed (iron dextran) and Dexeferrum (iron
    dextra) and feraccru treatment penetration.
    However, the growth of this sector is being
    hindered by emerging anemia management therapies
    and associated risks.
  • The report analyzes the global iron products
    industry along with an extensive coverage of
    global, Europe and the US I.V. iron market. The
    global IV iron market witnesses intense
    competition with numerous top notch players such
    as Galenica Pharmaceuticals, Actavis Inc, AMAG
    Pharmaceuticals operating in the marketplace
    along with small budding players. As a part of
    analysis of fierce competition prevailing in the
    industry, product contention has been presented
    in the report. The company profiles of leading
    aforementioned players in the market are also
    incorporated in the report.
  • By combining SPSS Inc.s data integration and
    analysis capabilities with our relevant findings,
    we have predicted the future growth of the
    industry. We employed various significant
    variables that have an impact on this industry
    and created regression models with SPSS Base to
    determine the future direction of the industry.
    Before deploying the regression model, the
    relationship between several independent or
    predictor variables and the dependent variable
    was analyzed using standard SPSS output,
    including charts, tables and tests.

3
Growing number of dialysis patients, ageing
population and ERSD patients to drive the market
Global I.V. Iron Drugs Market by Value (2010-2015)
  • The global I.V. iron market was valued at US...
    million in 2015, as compared to US... million in
    2013, showing an incline of .
  • As of 2015, in terms of product category, Venofer
    accounted for the largest market share of in
    the global I.V. iron market, followed by
    Ferinject with of the market share. ISS and
    Feraheme held and share of the total
    respectively.
  • As of 2015, oral iron products held the largest
    share of share in the global iron products
    market, followed by intravenous products with
    share of .

Global I.V. Iron Drugs Market Share by Product
(2015)
Global Iron Products Market Share by Segment
(2015)
4
Increasing healthcare expenditure and economic
development are also driving the market.
The US I.V. Iron Drug Market by Value (2010-2015)
  • The US I.V. iron market marked an incline of
    to reach US... million in 2015, as compared to
    US... million in the prior year.
  • As of 2015, Venofer accounted for the largest
    market share of in the total US I.V. iron
    market followed by Injectafer with share of .
    Feraheme and Gluconate held and share
    respectively.
  • As of 2015, European I.V. iron drug market
    declined by to reach US... million, due to
    currency fluctuation.

The US I.V. Iron Drug Market Share by Product
(2015)
European I.V. Iron Drug Market by Value
(2010-2015)
5
The future growth would mainly be driven by
growing ERSD patients, increasing cases of
hypertension and number of dialysis patients.
Global I.V. Iron Drug Market Forecast (2014-2019E)
  • The global I.V. iron drugs market is estimated to
    grow at a CAGR of from US... million in 2014
    to US... million in 2019.
  • The global I.V. iron drugs market is showing a
    significant growth owing to improvement in the
    quality of treatment outside dialysis, increasing
    number of dialysis patients, growing number of
    ERSD patients worldwide and growing ageing
    population.

6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
I.V. Iron Drugs Market . To know more about
this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com
About PowerShow.com